Navigation Links
Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time

Researchers from the department of urology in a hospital in Switzerland who investigated whether chemotherapeutic response to hormone-refractory prostate cancer could be measured via changes in prostate-specific antigen (PSA) found that prostate cancer doubling time may be an auxiliary marker of response to chemotherapy// in patients with hormone refractory prostate cancer.

The study was carried out with forty men who had hormone refractory prostate cancer and bi-dimensionally measurable metastases in the lymph nodes or visceral organs. The investigators calculated PSA doubling time among the patients who had a rising PSA during chemotherapy. Patients' objective best response for any of the chemotherapeutic regimens they were taking was partial remission in 6 patients (15%), stable disease in 13 (32%) and progressive disease in 21 (53%). PSA remained stable or decreased in 4 of the 6 patients who experienced a partial remission (67%), in 7 of the 13 who had stable disease (54%) and in only 4 of the 21 who had progressive disease (19%). There was a significant association between PSA and objective response. The pateints' median PSA doubling time was also studied. Among those patients who had a rising PSA, it was 238 days in patients who experienced a partial response, 224 days in those with stable disease and 113 days in patients with progressive disease.

The researchers concluded that this study indicated that PSA doubling time could be used as an auxiliary endpoint for the evaluation of response to chemotherapy in patients with hormone refractory prostate cancer and therefore could indirectly be used to assess response to chemotherapy in patients with bone metastases.


'"/>




Page: 1

Related medicine news :

1. Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture
2. Reflecting On Personal Values Can Lower Stress Responses
3. Chromosome Ends Trigger DNA Damage Response For Telomere Protection
4. Good Response from Pregnant Women in Delhi for Free ART Therapy
5. Immune Response Of Human Beings Can Be Re-energized
6. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
7. Placing a Finger on Responses to Placebo Types
8. Women Portray Stronger Immune Response As Compared to Men, Study Suggests
9. WHO Commends Indias Bird Flu Response
10. Genes And Environmental Factors Determine Stress Response
11. Immune Response To Flu Shots Influenced By Bereavement And Marital Status
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads ... not found any of them to be very practical. She wanted to write a ... make changes in their health. It prompted her in writing “ A Clear Path ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/22/2017)... , ... April 22, 2017 , ... Ecommerce sales have ... States estimated to be $394.9 billion. The consequences of rapid innovation and growth ... the limits of technology, it is every business and individual’s job to give something ...
(Date:4/22/2017)... ... 2017 , ... The San Juan Capistrano summer camp team at the Boys and ... for summer camps to provide physical activities for all campers. To read the report, ... , With an increase in specialty camps that focus on what the report terms as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Uro/Gyn and Gynecology markets with innovative and proprietary products, ... March 31, 2017 after the market close on Tuesday, ... host a conference call and webcast to discuss its ... 2017 at 4:30 p.m. Eastern Time (3:30 p.m. Central ...
Breaking Medicine Technology: